Evaluation of Prucalopride in Subjects With Moderate and Severe Hepatic Impairment

NCT01134185 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment

Interventions

DRUG: prucalopride
DRUG: prucalopride
DRUG: prucalopride

Sponsor

Movetis